Rowe v. Naphcare, Inc.

District Court, D. Nevada·Decided August 4, 2021·No. 2:18-cv-00568·Unknown

Opinion

UNITED STATES DISTRICT COURT * * *

STEVEN ROWE Case No. 2:18-cv-00568-RFB-DJA Plaintiff, v. NAPHCARE, INC. et al., Defendants.

I. INTRODUCTION Before the Court is Defendant’s Motion for Summary Judgment. ECF No. 47. For the following reasons, the Court grants Defendants’ motion in part and denies it in part.

II. PROCEDURAL BACKGROUND Plaintiff commenced this action by filing a complaint on March 29, 2017. ECF No. 1. On March 5, 2019, Defendants filed an answer. ECF No. 26. On July 3, 2018, Defendants filed a motion to dismiss which this Court denied. ECF Nos. 20, 24. On March 3, 2020, Defendants filed a motion for summary judgment. Plaintiff responded on March 24, 2020 and Defendants replied on April 7, 2020. ECF Nos. 49, 51. This Court held a hearing regarding Defendants’ motion for summary judgment on March 3, 2021. ECF No. 54. This written order now follows.

III. FACTUAL FINDINGS The Court makes the following findings of undisputed and disputed facts: a. Undisputed Facts The Court finds the following facts to be undisputed. On April 15, 2016, Plaintiff Rowe was booked into Clark County Detention Center (“CCDC”). At his initial screening assessment, Plaintiff informed Defendant Trinidad Drozeski, EMT that he had a genetic skin condition, Hailey- Hailey disease, a genetic disorder rendering Plaintiff susceptible to a risk of infection if exposed and Plaintiff warned Defendant that he had one small lesion under his armpit. Defendant Drozeski failed to include this information in Plaintiff’s Rowe assessment and instead wrote in the screening notes that Plaintiff had “no injuries or infections.” Despite knowing of Plaintiff’s risk to unsanitary conditions, he ordered Plaintiff to put on a CCDC shirt. After putting on the shirt, Plaintiff’s armpit lesion started to grow substantially. Plaintiff Rowe was then placed in the 4L CCDC medical unit for detoxification. Later that day, Defendant Kristin Pagaduan, RN examined Plaintiff. Rowe informed her of his skin condition that is highly subject to exacerbation because of unsanitary conditions. In the medical notes, Defendant Pagaduan identified that Plaintiff had a rash in his armpit and Hailey-Hailey disease. Later that evening, Defendant Andrea Balogh, PA, created Plaintiff’s medical treatment plan and prescribed medication: topical corticosteroid and antifungal treatments for Hailey-Hailey disease; Tylenol and x-ray for his arm. Defendant also designated Plaintiff for “standard booking and housing procedures.” Over the course of the day on April 16, 2016, Plaintiff’s skin condition continued to worsen. On April 17, 2016, Defendant Hong Ye Huang, NP examined Plaintiff and noted “no lesions or rashes,” and ordered that Plaintiff be transferred to general population. While in general population, Plaintiff’s skin condition was exacerbated, and he developed more skin lesions. On April 18, 2016, Defendant Dr. Harry Duran, MD examined Plaintiff and determined that he had an exacerbation of Hailey-Hailey syndrome with multiple areas of plaque and skin breakdown and discharge. Defendant Duran changed topical medications to treat this condition. On April 19, 2016, Plaintiff submitted a medical kite regarding his skin condition and the risk of further infection. Also on this day, Defendant Mylissa Peck, LPN took Plaintiff’s blood pressure and noted it in Plaintiff’s medical fille. Over the next 48 hours while in general population, Plaintiff’s skin condition continued to worsen. On April 21, 2016, Defendant Valeri Gibson, LPN, took Plaintiff’s blood pressure and updated his medical file. On April 23, 2016, Defendant Eileen Murillo, RN noted in Plaintiff’s chart that his rashes were exacerbated, and she administered medication. On April 24, 2016, Defendant Daniel Navarro, NP also examined Plaintiff and noted that Rowe had chronic intermittent skin rash. Later that day, Defendant Ray Montenegro, NP examined Plaintiff and noted that he had lesions on his chest and body. On April 25, 2016, Plaintiff submitted another medical kite requesting an emergency visit from a doctor. Later that day, Defendant Duran requested that Plaintiff be transferred to 4L for medical observation. Defendant Duran also examined Rowe, noting improvement of some lesions, but groin lesions were irritated. Defendant Duran also indicated that Plaintiff needed to be transferred to 4L for continued care. On April 26, 2016, Defendant Olga, LPN, noted that Plaintiff’s medication had been ordered. Later that day, Defendant Duran examined Plaintiff and noted that antifungal medicine be administered for the lesions on Plaintiff’s body. On April 27, 2016, Defendant Kelly Woodring, LPN administered the antifungal medicine. Over the following days Defendant Duran examined Plaintiff, noting his lesions were improving. Plaintiff was released from CCDC on May 3, 2016, and he was able to receive additional treatment. b. Disputed Facts The parties dispute the degree to which Rowe’s condition may have worsened and then improved.

Free access — add to your briefcase to read the full text and ask questions with AI

Rowe v. Naphcare, Inc., (D. Nev. 2021).

Rowe v. Naphcare, Inc. (Rowe v. Naphcare, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Monell v. New York City Dept. of Social Servs.
436 U.S. 658 (Supreme Court, 1978)
West v. Atkins
487 U.S. 42 (Supreme Court, 1988)
Scott v. Harris
550 U.S. 372 (Supreme Court, 2007)
Hoffman v. Applicators Sales & Service, Inc.
439 F.3d 9 (First Circuit, 2006)
Cion Peralta v. T. Dillard
744 F.3d 1076 (Ninth Circuit, 2014)
Gonzalez Ex Rel. Gonzalez v. City of Anaheim
747 F.3d 789 (Ninth Circuit, 2014)